439 related articles for article (PubMed ID: 14521485)
1. Rationale for current therapies in Parkinson's disease.
Romrell J; Fernandez HH; Okun MS
Expert Opin Pharmacother; 2003 Oct; 4(10):1747-61. PubMed ID: 14521485
[TBL] [Abstract][Full Text] [Related]
2. Current and experimental treatments of Parkinson disease: A guide for neuroscientists.
Oertel W; Schulz JB
J Neurochem; 2016 Oct; 139 Suppl 1():325-337. PubMed ID: 27577098
[TBL] [Abstract][Full Text] [Related]
3. Non-dopaminergic treatments for motor control in Parkinson's disease.
Fox SH
Drugs; 2013 Sep; 73(13):1405-15. PubMed ID: 23917951
[TBL] [Abstract][Full Text] [Related]
4. Medical management of levodopa-associated motor complications in patients with Parkinson's disease.
Jankovic J; Stacy M
CNS Drugs; 2007; 21(8):677-92. PubMed ID: 17630819
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complications.
Stowe R; Ives N; Clarke CE; Deane K; ; Wheatley K; Gray R; Handley K; Furmston A
Cochrane Database Syst Rev; 2010 Jul; (7):CD007166. PubMed ID: 20614454
[TBL] [Abstract][Full Text] [Related]
6. Early Parkinson's disease: what is the best approach to treatment.
Hristova AH; Koller WC
Drugs Aging; 2000 Sep; 17(3):165-81. PubMed ID: 11043817
[TBL] [Abstract][Full Text] [Related]
7. Current pharmacotherapeutic treatment options in Parkinson's disease.
Rezak M
Dis Mon; 2007 Apr; 53(4):214-22. PubMed ID: 17586328
[TBL] [Abstract][Full Text] [Related]
8. Alternatives to levodopa in the initial treatment of early Parkinson's disease.
Lees A
Drugs Aging; 2005; 22(9):731-40. PubMed ID: 16156677
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease: medical treatment of moderate to advanced disease.
Suchowersky O
Curr Neurol Neurosci Rep; 2002 Jul; 2(4):310-6. PubMed ID: 12044250
[TBL] [Abstract][Full Text] [Related]
10. Community and long-term care management of Parkinson's disease in the elderly: focus on monoamine oxidase type B inhibitors.
Chen JJ; Fernandez HH
Drugs Aging; 2007; 24(8):663-80. PubMed ID: 17702535
[TBL] [Abstract][Full Text] [Related]
11. Recent developments in the pharmacological treatment of Parkinson's disease.
Tuite P; Riss J
Expert Opin Investig Drugs; 2003 Aug; 12(8):1335-52. PubMed ID: 12882620
[TBL] [Abstract][Full Text] [Related]
12. Understanding Parkinson's disease: an update on current diagnostic and treatment strategies.
Pahwa R
J Am Med Dir Assoc; 2006 Sep; 7(7 Suppl 2):4-10. PubMed ID: 17948613
[TBL] [Abstract][Full Text] [Related]
13. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.
Friedman JH; Factor SA
Mov Disord; 2000 Mar; 15(2):201-11. PubMed ID: 10752567
[TBL] [Abstract][Full Text] [Related]
14. Current strategies in the treatment of Parkinson's disease and a personalized approach to management.
Diaz NL; Waters CH
Expert Rev Neurother; 2009 Dec; 9(12):1781-9. PubMed ID: 19951137
[TBL] [Abstract][Full Text] [Related]
15. Treatment options for early Parkinson's disease.
Stacy M; Brownlee HJ
Am Fam Physician; 1996 Mar; 53(4):1281-7. PubMed ID: 8629572
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatment of Parkinson disease: a review.
Connolly BS; Lang AE
JAMA; 2014 Apr 23-30; 311(16):1670-83. PubMed ID: 24756517
[TBL] [Abstract][Full Text] [Related]
17. Parkinson's disease: managing symptoms and preserving function.
Sweeney PJ
Geriatrics; 1995 Sep; 50(9):24-31. PubMed ID: 7672615
[TBL] [Abstract][Full Text] [Related]
18. Parkinson's disease: drug therapy.
Oertel WH; Quinn NP
Baillieres Clin Neurol; 1997 Apr; 6(1):89-108. PubMed ID: 9426870
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy for Parkinson's disease.
Chen JJ; Swope DM
Pharmacotherapy; 2007 Dec; 27(12 Pt 2):161S-173S. PubMed ID: 18041936
[TBL] [Abstract][Full Text] [Related]
20. [Initial treatment of Parkinson's disease].
Kulisevsky J; López-Villegas D
Rev Neurol; 1997 Aug; 25 Suppl 2():S163-9. PubMed ID: 9280684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
